Innoviva posts second-quarter 2026 results, adds Dr. Reddy's licensing deal and new Nortiva Bio unit
IST net product sales rose 46% year over year in the quarter as Innoviva signed an antibiotic licensing pact with Dr. Reddy's and stood up a new long-acting oral drug delivery subsidiary.
SEC filing